Cargando…
The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
BACKGROUND: There are several commercially available agents to treat female pattern hair loss (FPHL), including minoxidil solution, anti-androgen agents and mineral supplements. However, these treatments are not always satisfactory. We report the results of a clinical trial of 17α-estradiol (Ell-Cra...
Autores principales: | Kim, Jae-Hong, Lee, Sung Yul, Lee, Hae-Jin, Yoon, Na-Young, Lee, Won-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412238/ https://www.ncbi.nlm.nih.gov/pubmed/22879713 http://dx.doi.org/10.5021/ad.2012.24.3.295 |
Ejemplares similares
-
Dynamic Mechanical Properties and Microstructure of an (Al(0.5)CoCrFeNi)(0.95)Mo(0.025)C(0.025) High Entropy Alloy
por: Wang, Bingfeng, et al.
Publicado: (2019) -
Comparison of efficacy and safety of topical 1% nadifloxacin and tretinoin 0.025% combination therapy with 1% clindamycin and tretinoin 0.025% combination therapy in patients of mild-to-moderate acne
por: Deshmukh, Swapnil Narayan, et al.
Publicado: (2018) -
Cryochemically Processed Li(1+y)Mn(1.95)Ni(0.025)Co(0.025)O(4) (y = 0, 0.1) Cathode Materials for Li-Ion Batteries
por: Normakhmedov, Ofok O., et al.
Publicado: (2018) -
Experimental study of loop shape using 0.025-inch ERCP guidewires (with videos)
por: Ogura, Takeshi, et al.
Publicado: (2021) -
Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial
por: McLaurin, Eugene, et al.
Publicado: (2018)